Cellectis S.A. Files Form 6-K for December 2024
Ticker: CLLS · Form: 6-K · Filed: Dec 10, 2024 · CIK: 1627281
Sentiment: neutral
Topics: reporting, sec-filing
TL;DR
Cellectis filed a 6-K on Dec 10, 2024, incorporating press releases into its F-3/S-8 filings.
AI Summary
Cellectis S.A. filed a Form 6-K on December 10, 2024, to report information for the month of December 2024. This filing includes a press release that will be incorporated by reference into the company's existing registration statements on Form F-3 and Form S-8.
Why It Matters
This filing serves as an update for investors and stakeholders regarding the company's ongoing reporting obligations and incorporates previous disclosures into active registration statements.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material financial information or significant operational updates.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- 001-36891 (company) — Commission File Number
- 20241210 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form F-3 (document) — Incorporated by reference into
- Form S-8 (document) — Incorporated by reference into
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is filed to report information for the month of December 2024 and includes a press release that is incorporated by reference into the company's registration statements.
When was this Form 6-K filed?
This Form 6-K was filed on December 10, 2024.
What are the company's principal executive offices?
The company's principal executive offices are located at 8, rue de la Croix Jarry, 75013 Paris, France.
Which registration statements will this filing be incorporated into?
This filing will be incorporated by reference into the company's registration statements on Form F-3 (No. 333-265826) and Form S-8 (Nos. 333-204205, 333-214884, 333-222482, 333-227717, 333-258514, 333-267760 and 333-273777).
Does Cellectis file annual reports under Form 20-F or 40-F?
Cellectis indicates it files annual reports under cover of Form 20-F.
Filing Stats: 211 words · 1 min read · ~1 pages · Grade level 9.2 · Accepted 2024-12-10 16:35:15
Filing Documents
- f6k_121024.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 7KB
- 0001171843-24-006862.txt ( ) — 13KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: December 10, 2024 /s/ Andr Choulika Andr Choulika Chief Executive Officer